Table 2.

Maternal and neonatal outcomes by mode of delivery.

	Vaginal delivery	Cesarean delivery
	No. (%) (n = 416)a	No. (%) (n = 603)b
Comorbiditiesc	32 (29.36%)	60 (27.91%)
INDICATIONS FOR CESAREAN DELIVERYd
Due to obstetrical indications	NA	407 (68.52%)
Due to concern about Covid-19	NA	187 (31.48%)
MATERNAL OUTCOMES
Maternal deathse (secondary outcome)	1 (0.24%)	11 (1.82%)
NEONATAL OUTCOMES
SARS-CoV-2 test positivityf (primary outcome)	9 (2.16%)	25 (4.05%)
Neonatal deathsg (secondary outcome)	0 (0.00%)	6 (0.97%)

SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2; NA, Not applicable.

^a416 pregnant women gave birth vaginally, including one set of twins.

^b603 women gave birth by cesarean section, including one set of triplets and thirteen sets of twins.

^cDetailed information on comorbidities was available for 324 pregnant women. Of the 109 women who delivered vaginally, 32 had one or more comorbidities. Of the 215 women who had a cesarean delivery, 60 had one or more comorbidities.

^dDetailed information on the indication for cesarean section was available for 594 pregnant women.

^eExcluding two women who died in the second trimester before delivery.

^fIncluding 31 reverse transcriptase-polymerase chain reaction positive neonates and three elevated Immunoglobulin M levels for SARS-CoV-2 neonates.

^gExcluding nine stillbirths.